Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

被引：0
|
作者：
Mikio Sugimoto
Takuma Kato
Yoichiro Tohi
Yosuke Shimizu
Ryuji Matsumoto
Takahiro Inoue
Yutaka Takezawa
Kimihiko Masui
Hiroshi Sasaki
Hiromi Hirama
Shiro Saito
Shin Egawa
Toshiyuki Kamoto
Satoshi Teramukai
Shinsuke Kojima
Takashi Kikuchi
Yoshiyuki Kakehi
机构：
[1] Kagawa University,Department of Urology, Faculty of Medicine
[2] Kobe City Nishi-Kobe Medical Center,Department of Urology
[3] Hokkaido University Graduate School of Medicine,Department of Urology
[4] Kyoto University,Department of Urology, Graduate School of Medicine
[5] Isesaki Municipal Hospital,Department of Urology
[6] Otsu City Hospital,Department of Urology
[7] Jikei University School of Medicine,Department of Urology
[8] National Hospital Organization Tokyo Medical Center,Department of Urology
[9] University of Miyazaki,Department of Urology, Faculty of Medicine
[10] Kyoto Prefectural University of Medicine,Department of Biostatistics
[11] Foundation for Biomedical Research and Innovation at Kobe Translational Research Center for Medical Innovation,undefined
来源：
BMC Urology | / 22卷
关键词：
Combined androgen blockade; Enzalutamide; Non-metastatic castration-resistant prostate cancer; Progression-free survival; Radical treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
    Alkhudair, Nora A.
    SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (03) : 368 - 372
  • [32] Real-world use of darolutamide, enzalutamide, and apalutamide for non-metastatic castration-resistant prostate cancer (DEAR).
    George, Daniel J.
    Khan, Nasreen
    Constantinovici, Niculae
    Khan, Javeed
    Chen, Guifang
    Xu, Julie
    Ortiz, Jorge A.
    Morgans, Alicia K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [33] PREDICTORS OF TIME TO METASTASIS IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Moreira, Daniel
    Howard, Lauren
    Sourbeer, Katie
    Kundich, Robert
    Kane, Christopher
    Aronson, William
    Terris, Martha
    Cooperberg, Matthew
    Amling, Christopher
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2014, 191 (04): : E921 - E921
  • [34] MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF APALUTAMIDE AND ENZALUTAMIDE IN THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Chowdhury, S.
    Oudard, S.
    Hadaschik, B. A.
    Uemura, H.
    Joniau, S.
    Pilon, D.
    Ladouceur, M.
    Behl, A.
    Liu, J.
    Dearden, L.
    Sermon, J.
    Van Sanden, S.
    Diels, J.
    VALUE IN HEALTH, 2018, 21 : S20 - S21
  • [35] Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
    Small, E. J.
    Saad, F.
    Chowdhury, S.
    Oudard, S.
    Hadaschik, B. A.
    Graff, J. N.
    Olmos, D.
    Mainwaring, P. N.
    Lee, J. Y.
    Uemura, H.
    De Porre, P.
    Smith, A. A.
    Zhang, K.
    Lopez-Gitlitz, A.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2019, 30 (11) : 1813 - 1820
  • [36] Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management
    Tartarone, Alfredo
    Lerose, Rosa
    Tartarone, Marina
    MEDICAL ONCOLOGY, 2022, 39 (07)
  • [37] Enzalutamide Treatment in Metastatic Castration-resistant Prostate Cancer: Before and after Docetaxel
    Bilgetekin, Irem
    Basal, Fatma Bugdayci
    Cinkir, Havva Yesil
    Esin, Ece
    Oksuzoglu, Berna
    Demirci, Umut
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (08): : 815 - 821
  • [38] A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE
    Payne, Heather
    Robinson, Angus
    Rappe, Bernard
    Hilman, Serena
    De Giorgi, Ugo
    Joniau, Steven
    Bordonaro, Roberto
    Mallick, Stephane
    Dourthe, Louis-Marie
    Flores, Moises Mira
    Guma, Josep
    Baron, Benoit
    Duran, Aurea
    Pranzo, Alessandra
    Serikoff, Alexis
    Mott, David
    Herdman, Mike
    Pavesi, Marco
    De Santis, Maria
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (05) : 837 - 846
  • [39] PELVIC EXENTERATION IN PATIENTS WITH NON-METASTATIC, LOCALLY ADVANCED CASTRATION-RESISTANT PROSTATE CANCER
    Donahue, Timothy F.
    Morris, Michael J.
    Slovin, Susan F.
    Scher, Howard I.
    Scardino, Peter T.
    Bochner, Bernard H.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1038 - E1038
  • [40] Adverse events and costs among non-metastatic castration-resistant prostate cancer patients
    Appukkuttan, Sreevalsa
    Yao, Jianying
    Partridge, Jamie
    Kong, Sheldon X.
    Parkin, Jacqueline
    Freedland, Stephen J.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 145 - 152
12345